We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
+1.34%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$42.2B
AUM Growth
-$1.23B
(-2.8%)
Cap. Flow
-$952M
Cap. Flow
% of AUM
-2.26%
Top 10 Holdings %
Top 10 Hldgs %
14.57%
Holding
2,171
New
150
Increased
772
Reduced
960
Closed
152
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$156M |
| 2 |
Prologis
PLD
|
+$150M |
| 3 |
Chevron
CVX
|
+$109M |
| 4 |
Qualcomm
QCOM
|
+$101M |
| 5 |
Paycom
PAYC
|
+$90.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
FUSN
Fusion Pharmaceuticals Inc. Common Shares
FUSN
|
+$230M |
| 2 |
Kimberly-Clark
KMB
|
+$160M |
| 3 |
Stanley Black & Decker
SWK
|
+$130M |
| 4 |
Paychex
PAYX
|
+$113M |
| 5 |
Dominion Energy
D
|
+$105M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.81% |
| 2 | Healthcare | 17.11% |
| 3 | Financials | 12.73% |
| 4 | Industrials | 9.87% |
| 5 | Consumer Discretionary | 9.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CVSA
1776
Covista Inc
CVSA
$4.3B
| $10K | ﹤0.01% |
+147
| New | +$8.63K |
|
1777
Orion Group Holdings
ORN
$367M
| $9.99K | ﹤0.01% |
1,051
+426
| +68% | +$3.77K |
|
1778
Clearwater Paper
CLW
$341M
| $9.98K | ﹤0.01% |
206
-2
| -1% | -$94 |
|
1779
MannKind Corp
MNKD
$1.14B
| $9.83K | ﹤0.01% |
1,883
+1,284
| +214% | +$5.83K |
|
1780
Lincoln Educational Services
LINC
$806M
| $9.8K | ﹤0.01% |
826
-42
| -5% | -$458 |
|
1781
iShares MSCI Japan ETF
EWJ
$23.3B
| $9.76K | ﹤0.01% |
143
-44
| -24% | -$3K |
|
|
CIO
1782
DELISTED
City Office REIT
CIO
| $9.73K | ﹤0.01% |
1,953
| – | – |
|
1783
Dana Inc
DAN
$3.24B
| $9.65K | ﹤0.01% |
+796
| New | +$10.4K |
|
1784
iShares International Select Dividend ETF
IDV
$8.61B
| $9.38K | ﹤0.01% |
+339
| New | +$9.63K |
|
|
PRSU
1785
Pursuit Attractions and Hospitality Inc
PRSU
$1.34B
| $9.25K | ﹤0.01% |
272
| – | – |
|
1786
KE Holdings
BEKE
$17.9B
| $9.21K | ﹤0.01% |
651
+180
| +38% | +$2.82K |
|
1787
Metallus
MTUS
$793M
| $9.18K | ﹤0.01% |
453
+329
| +265% | +$7.2K |
|
1788
Conduent
CNDT
$255M
| $9.12K | ﹤0.01% |
2,797
-1
| -0% | -$3 |
|
1789
Tyra Biosciences
TYRA
$1.52B
| $9.05K | ﹤0.01% |
566
-147
| -21% | -$2.53K |
|
1790
Limbach Holdings
LMB
$602M
| $8.88K | ﹤0.01% |
156
+31
| +25% | +$1.53K |
|
|
OPI
1791
DELISTED
Office Properties Income Trust
OPI
| $8.84K | ﹤0.01% |
4,334
-602,366
| -99% | -$1.31M |
|
1792
Northeast Community Bancorp
NECB
$375M
| $8.75K | ﹤0.01% |
491
| – | – |
|
1793
Apple Hospitality REIT
APLE
$3.65B
| $8.72K | ﹤0.01% |
600
+24
| +4% | +$358 |
|
|
ALLK
1794
DELISTED
Allakos
ALLK
| $8.67K | ﹤0.01% |
8,671
-49
| -0.6% | -$58 |
|
1795
Rallybio
RLYB
$91.4M
| $8.33K | ﹤0.01% |
777
+560
| +258% | +$7.59K |
|
|
TERN
1796
DELISTED
Terns Pharmaceuticals
TERN
| $8.28K | ﹤0.01% |
+1,216
| New | +$7.37K |
|
|
GRAL
1797
GRAIL Inc
GRAL
$3.39B
| $8.15K | ﹤0.01% |
+530
| New | +$8.6K |
|
1798
ANI Pharmaceuticals
ANIP
$1.66B
| $8.02K | ﹤0.01% |
126
+6
| +5% | +$390 |
|
1799
Axos Financial
AX
$5.26B
| $8K | ﹤0.01% |
140
| – | – |
|
1800
Beazer Homes USA
BZH
$890M
| $8K | ﹤0.01% |
291
-25
| -8% | -$709 |
|
Similar funds
Federated Hermes's Q2 2024 Portfolio in Review
As of Q2 2024, Federated Hermes held 2,171 positions worth $42.2B, down 2.8% from $43.4B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Federated Hermes's Q2 2024 filing shows 150 new, 772 increased, 960 reduced and 152 closed positions. Its largest new stake was Loar Holdings: 729,296 shares worth $39M. The largest sale was Fusion Pharmaceuticals Inc. Common Shares, an estimated $230M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 17% a quarter earlier, followed by Healthcare and Financials.
- Federated Hermes's largest Q2 2024 buy was Loar Holdings: 729,296 shares worth $39M.
- Federated Hermes added most to Bristol-Myers Squibb in Q2 2024, an estimated $156M increase.
- Federated Hermes's biggest Q2 2024 reduction was Kimberly-Clark, cutting an estimated $160M.
- Federated Hermes fully exited Fusion Pharmaceuticals Inc. Common Shares in Q2 2024, selling an estimated $230M.
- Federated Hermes's ten largest holdings make up 15% of its $42.2B portfolio in Q2 2024.
- Federated Hermes opened 150 new positions and closed 152 in Q2 2024.
- Federated Hermes's portfolio value fell 2.8% quarter-over-quarter to $42.2B.
Based on Federated Hermes's 13F filing for Q2 2024, filed 8 Aug 2024.